noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

California Attorney General's Office

Attorney General Bonta Secures Permanent Decision Allowing Mental Grant[...]
California Attorney General's Office

Attorney General Bonta and Governor Newsom Secure Major Win in State’s[...]
ASHI - American Society of Home[...]

ASHI and NRSB Announce Joint Collaboration to Support Education and[...]

Healthcare

Rhythm Pharmaceuticals Inc.

12/19/2025 | Press release | Distributed by Public on 12/19/2025 15:05

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 16, 2025, Camille L. Bedrosian, M.D. notified the Board of Directors (the "Board") of Rhythm Pharmaceuticals, Inc. (the "Company") of her decision to resign from the Board, effective immediately. Dr. Bedrosian currently serves on the Compensation & Management Development Committee, and the Governance and Nominating Committee. Dr. Bedrosian's decision to resign was not due to any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices.

Rhythm Pharmaceuticals Inc. published this content on December 19, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 19, 2025 at 21:06 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]